Clinical trial
Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive…
NCT00149175 · Institut National de la Santé Et de la Recherche Médicale, France, Other · Completed
Key facts
| NCT number | NCT00149175 |
|---|---|
| Title | Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment |
| Official title | Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment |
| Lead sponsor | Institut National de la Santé Et de la Recherche Médicale, France, Other |
| Collaborators | Aventis Pharmaceuticals Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Alzheimer's Disease, Dementia, Neurodegenerative Disorders |
| Intervention type | Other |
| Interventions | Blood sampling, skin biopsy |
| Enrollment | 2,256 |
| Start date | Dec 1, 2002 |
| Primary completion | Dec 31, 2020 |
| Completion | Dec 31, 2020 |
| First posted | Sep 8, 2005 |
| Last update posted | Jan 23, 2025 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: